Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77
Adenosine is generated in the microenvironment of emerging thymocytes through normal mechanisms of lymphocyte selection. In a normal thymus, most of the adenosine is catabolized by adenosine deaminase; however, in an environment where up to 95% of the cells undergo programmed cell death, a sufficient amount of adenosine is accumulated to trigger cell surface adenosine receptors. Here we show that accumulated adenosine can induce apoptosis in immature mouse thymocytes, mostly via adenosine A(2A) receptors. The signaling pathway is coupled to adenylate cyclase activation, induction of the Nur77 transcription factor, Nur77-dependent genes, such as Fas ligand and TRAIL, and the pro-apoptotic BH3-only protein Bim. We analyzed several knockout and transgenic mouse lines and found that adenosine-induced killing of mouse thymocytes requires Bim, occurs independently of "death receptor" signaling and is inhibited by Bcl-2 and Nur77. Collectively our data demonstrate that adenosine-induced cell death involves signaling pathways originally found in negative selection of thymocytes and suggest a determining role of Bim and a regulatory role for Nur77.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2006 |
---|---|
Erschienen: |
2006 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
European journal of immunology - 36(2006), 6 vom: 12. Juni, Seite 1559-71 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kiss, Ildikó [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 14.08.2006 Date Revised 19.11.2015 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM162564562 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM162564562 | ||
003 | DE-627 | ||
005 | 20231223094504.0 | ||
007 | tu | ||
008 | 231223s2006 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0542.xml |
035 | |a (DE-627)NLM162564562 | ||
035 | |a (NLM)16673448 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kiss, Ildikó |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77 |
264 | 1 | |c 2006 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 14.08.2006 | ||
500 | |a Date Revised 19.11.2015 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Adenosine is generated in the microenvironment of emerging thymocytes through normal mechanisms of lymphocyte selection. In a normal thymus, most of the adenosine is catabolized by adenosine deaminase; however, in an environment where up to 95% of the cells undergo programmed cell death, a sufficient amount of adenosine is accumulated to trigger cell surface adenosine receptors. Here we show that accumulated adenosine can induce apoptosis in immature mouse thymocytes, mostly via adenosine A(2A) receptors. The signaling pathway is coupled to adenylate cyclase activation, induction of the Nur77 transcription factor, Nur77-dependent genes, such as Fas ligand and TRAIL, and the pro-apoptotic BH3-only protein Bim. We analyzed several knockout and transgenic mouse lines and found that adenosine-induced killing of mouse thymocytes requires Bim, occurs independently of "death receptor" signaling and is inhibited by Bcl-2 and Nur77. Collectively our data demonstrate that adenosine-induced cell death involves signaling pathways originally found in negative selection of thymocytes and suggest a determining role of Bim and a regulatory role for Nur77 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a BH3 Interacting Domain Death Agonist Protein |2 NLM | |
650 | 7 | |a Bid protein, mouse |2 NLM | |
650 | 7 | |a DNA-Binding Proteins |2 NLM | |
650 | 7 | |a Fas Ligand Protein |2 NLM | |
650 | 7 | |a Fasl protein, mouse |2 NLM | |
650 | 7 | |a Membrane Glycoproteins |2 NLM | |
650 | 7 | |a Nr4a1 protein, mouse |2 NLM | |
650 | 7 | |a Nuclear Receptor Subfamily 4, Group A, Member 1 |2 NLM | |
650 | 7 | |a Proto-Oncogene Proteins c-bcl-2 |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a Receptor, Adenosine A2A |2 NLM | |
650 | 7 | |a Receptors, Cytoplasmic and Nuclear |2 NLM | |
650 | 7 | |a Receptors, Steroid |2 NLM | |
650 | 7 | |a Transcription Factors |2 NLM | |
650 | 7 | |a Tumor Necrosis Factors |2 NLM | |
650 | 7 | |a Cyclic AMP |2 NLM | |
650 | 7 | |a E0399OZS9N |2 NLM | |
650 | 7 | |a Adenylyl Cyclases |2 NLM | |
650 | 7 | |a EC 4.6.1.1 |2 NLM | |
650 | 7 | |a Adenosine |2 NLM | |
650 | 7 | |a K72T3FS567 |2 NLM | |
700 | 1 | |a Oskolás, Henriett |e verfasserin |4 aut | |
700 | 1 | |a Tóth, Réka |e verfasserin |4 aut | |
700 | 1 | |a Bouillet, Philippe |e verfasserin |4 aut | |
700 | 1 | |a Tóth, Katalin |e verfasserin |4 aut | |
700 | 1 | |a Fülöp, András |e verfasserin |4 aut | |
700 | 1 | |a Scholtz, Beáta |e verfasserin |4 aut | |
700 | 1 | |a Ledent, Catherine |e verfasserin |4 aut | |
700 | 1 | |a Fésüs, László |e verfasserin |4 aut | |
700 | 1 | |a Szondy, Zsuzsa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of immunology |d 1971 |g 36(2006), 6 vom: 12. Juni, Seite 1559-71 |w (DE-627)NLM000108723 |x 1521-4141 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2006 |g number:6 |g day:12 |g month:06 |g pages:1559-71 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2006 |e 6 |b 12 |c 06 |h 1559-71 |